These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 33318181)
1. Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model. Lohr KM; Frost B; Scherzer C; Feany MB Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33608-33618. PubMed ID: 33318181 [TBL] [Abstract][Full Text] [Related]
2. Tau promotes neurodegeneration through global chromatin relaxation. Frost B; Hemberg M; Lewis J; Feany MB Nat Neurosci; 2014 Mar; 17(3):357-66. PubMed ID: 24464041 [TBL] [Abstract][Full Text] [Related]
3. Alteration of mitochondrial homeostasis is an early event in a Palikaras K; Achanta K; Choi S; Akbari M; Bohr VA Aging (Albany NY); 2021 Nov; 13(21):23876-23894. PubMed ID: 34751671 [TBL] [Abstract][Full Text] [Related]
4. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation. Chanu SI; Sarkar S Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837 [TBL] [Abstract][Full Text] [Related]
5. Pathogenic Tau Causes a Toxic Depletion of Nuclear Calcium. Mahoney R; Ochoa Thomas E; Ramirez P; Miller HE; Beckmann A; Zuniga G; Dobrowolski R; Frost B Cell Rep; 2020 Jul; 32(2):107900. PubMed ID: 32668249 [TBL] [Abstract][Full Text] [Related]
6. Short-term exposure to dim light at night disrupts rhythmic behaviors and causes neurodegeneration in fly models of tauopathy and Alzheimer's disease. Kim M; Subramanian M; Cho YH; Kim GH; Lee E; Park JJ Biochem Biophys Res Commun; 2018 Jan; 495(2):1722-1729. PubMed ID: 29217196 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Bukhari H; Nithianandam V; Battaglia RA; Cicalo A; Sarkar S; Comjean A; Hu Y; Leventhal MJ; Dong X; Feany MB Genome Res; 2024 May; 34(4):590-605. PubMed ID: 38599684 [TBL] [Abstract][Full Text] [Related]
9. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038 [TBL] [Abstract][Full Text] [Related]
10. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621 [TBL] [Abstract][Full Text] [Related]
11. The role of MSUT-2 in tau neurotoxicity: a target for neuroprotection in tauopathy? Wheeler JM; Guthrie CR; Kraemer BC Biochem Soc Trans; 2010 Aug; 38(4):973-6. PubMed ID: 20658987 [TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models. Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease. Thackray AM; Lam B; Shahira Binti Ab Razak A; Yeo G; Bujdoso R Biochem J; 2020 Feb; 477(4):833-852. PubMed ID: 32108870 [TBL] [Abstract][Full Text] [Related]
14. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215 [TBL] [Abstract][Full Text] [Related]
16. The use of mouse models to study cell-to-cell transmission of pathological tau. Narasimhan S; Lee VMY Methods Cell Biol; 2017; 141():287-305. PubMed ID: 28882308 [TBL] [Abstract][Full Text] [Related]
17. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils. Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461 [TBL] [Abstract][Full Text] [Related]
19. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity. Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies. Ubhi KK; Shaibah H; Newman TA; Shepherd D; Mudher A Invert Neurosci; 2007 Sep; 7(3):165-71. PubMed ID: 17636367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]